RFK Jr already said he will investigate and find out who did this to hundreds of thousands…. was it by design? Hmmm
“Remdesivir is so lethal it got nicknamed ‘Run Death Is Near’ after it started killing thousands of Covid patients in the hospital,” wrote @StellaPaulNY in a previous report. “The experts claimed that Remdesivir would stop Covid; instead, it stopped kidney function, then blasted the liver and other organs.” What the US government never told you about Remdesivir is that by November 2020, the WHO said, “Do not use Remdesivir.” But instead, HHS added a 20% bonus on the entire hospital if they administered this liver and kidney-toxic drug. That 20% bonus could end up being a BIG pay day. Dr. Peter McCullough explains: “Now, I’m a doctor. I order medications in the hospital. If I order a series of injections of a particular medicine, the hospital doesn’t get a bonus on the entire hospital stay. If a hospital stay costs, let’s say, $500,000, that’s an extra $100,000. We’re talking big money for the use of a five-day course of remdesivir that the WHO says not to use.”
The US Govt BRIBED Hospitals to Administer a Kidney and Liver Toxic Drug
“Remdesivir is so lethal it got nicknamed ‘Run Death Is Near’ after it started killing thousands of Covid patients in the hospital,” wrote @StellaPaulNY in a previous report.
“The experts claimed that… pic.twitter.com/aeK5By4vWV
— The Vigilant Fox 🦊 (@VigilantFox) November 16, 2024
Were unvaccinated people targeted and ‘murdered’ by hospitals during COVID? Remdesivir, ventilators, drug cocktails — were part of hospital murder protocol. PollyTommey testifies about what hospital employees have confessed to her in this interview with Brighteon’s Mike Adams.
Were unvaccinated people targeted and ‘murdered’ by hospitals during COVID?
Remdesivir, ventilators, drug cocktails — were part of hospital murder protocol.
PollyTommey testifies about what hospital employees have confessed to her in this interview with Brighteon’s Mike Adams. pic.twitter.com/2HROmVnY0n
— Forever Trumper (@FanaTeresafana) November 11, 2024
Reevaluating Remdesivir’s Role in COVID-19 Treatment In October 2020, the FDA approved remdesivir for COVID-19 treatment, citing clinical trials indicating reduced recovery time in hospitalized patients. However, in November 2020, the WHO recommended against its use, stating no significant impact on mortality or disease progression. The U.S. Department of Health and Human Services implemented the New COVID-19 Treatments Add-On Payment (NCTAP) to incentivize hospitals administering treatments like remdesivir. This policy aimed to promote the use of emerging therapies during the pandemic, despite evolving international guidelines and concerns about potential adverse effects. – Siddarth
- “Considering that The New England Journal of Medicine (NEJM) reported, in May 2019, the use of remdesivir resulted in the highest mortality rate among participants in a trial of four investigational therapies for Ebola in the Democratic Republic of Congo, Younts said, “this informed consent is very misleading.” Ninety-three out of 175 (53.1 percent) patient deaths occurred in the group taking remdesivir. According to @DavisYounts
, “the whole point of informed consent—with all of the laws and litigation behind it—is that you should have the freedom and opportunity to make to make informed decisions regarding your health care.”
